145 related articles for article (PubMed ID: 8382106)
1. Incidence of hypercalcemia in patients with malignancy referred to a comprehensive cancer center.
Vassilopoulou-Sellin R; Newman BM; Taylor SH; Guinee VF
Cancer; 1993 Feb; 71(4):1309-12. PubMed ID: 8382106
[TBL] [Abstract][Full Text] [Related]
2. Brain metastases in patients diagnosed with a solid primary cancer during childhood: experience from a single referral cancer center.
Suki D; Khoury Abdulla R; Ding M; Khatua S; Sawaya R
J Neurosurg Pediatr; 2014 Oct; 14(4):372-85. PubMed ID: 25127097
[TBL] [Abstract][Full Text] [Related]
3. Lymphoma with hypercalcemia.
Walker IR
Can Med Assoc J; 1974 Nov; 111(9):928-30. PubMed ID: 4608255
[TBL] [Abstract][Full Text] [Related]
4. Hypercalcemia complicating childhood malignancies.
McKay C; Furman WL
Cancer; 1993 Jul; 72(1):256-60. PubMed ID: 8508415
[TBL] [Abstract][Full Text] [Related]
5. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
6. Corrected calcium versus ionized calcium measurements for identifying hypercalcemia in patients with multiple myeloma.
Buege MJ; Do B; Lee HC; Weber DM; Horowitz SB; Feng L; Qing Y; Shank BR
Cancer Treat Res Commun; 2019; 21():100159. PubMed ID: 31521048
[TBL] [Abstract][Full Text] [Related]
7. Calcitriol production in hypercalcemic and normocalcemic patients with non-Hodgkin lymphoma.
Seymour JF; Gagel RF; Hagemeister FB; Dimopoulos MA; Cabanillas F
Ann Intern Med; 1994 Nov; 121(9):633-40. PubMed ID: 7944070
[TBL] [Abstract][Full Text] [Related]
8. Hypercalcemia in children with rhabdomyosarcoma.
Kawasaki H; Takayama J; Nagasaki K; Yamaguchi K; Ohira M
J Pediatr Hematol Oncol; 1998; 20(4):327-9. PubMed ID: 9703006
[TBL] [Abstract][Full Text] [Related]
9. The incidence and prognostic significance of humoral hypercalcemia in renal cell carcinoma.
Fahn HJ; Lee YH; Chen MT; Huang JK; Chen KK; Chang LS
J Urol; 1991 Feb; 145(2):248-50. PubMed ID: 1988711
[TBL] [Abstract][Full Text] [Related]
10. Overview of cancer-related hypercalcemia: epidemiology and etiology.
Muggia FM
Semin Oncol; 1990 Apr; 17(2 Suppl 5):3-9. PubMed ID: 2185551
[TBL] [Abstract][Full Text] [Related]
11. A cross-sectional study to determine the prevalence of calcium metabolic disorder in malignant childhood cancers in patients admitted to the pediatric ward of Vali-Asr Hospital.
Moayeri H; Oloomi Z; Sambo SA
Acta Med Iran; 2011; 49(12):818-23. PubMed ID: 22174172
[TBL] [Abstract][Full Text] [Related]
12. Hypercalcemia of cancer in the digestive tract.
Monno S; Nagata A; Furuta S
J Clin Gastroenterol; 1987 Feb; 9(1):78-82. PubMed ID: 3559119
[TBL] [Abstract][Full Text] [Related]
13. Changing Incidence of Serum 25-Hydroxyvitamin D Values Above 50 ng/mL: A 10-Year Population-Based Study.
Dudenkov DV; Yawn BP; Oberhelman SS; Fischer PR; Singh RJ; Cha SS; Maxson JA; Quigg SM; Thacher TD
Mayo Clin Proc; 2015 May; 90(5):577-86. PubMed ID: 25939935
[TBL] [Abstract][Full Text] [Related]
14. Characteristics and outcome of severe hypercalcemia on admission to the emergency department: a retrospective cohort study.
Ravioli S; Lafranchi A; Exadaktylos AK; Haidinger M; Lindner G
Swiss Med Wkly; 2023 Apr; 153():40069. PubMed ID: 37191138
[TBL] [Abstract][Full Text] [Related]
15. Increased prevalence of primary hyperparathyroidism in treated breast cancer.
Fierabracci P; Pinchera A; Miccoli P; Conte PF; Vignali E; Zaccagnini M; Marcocci C; Giani C
J Endocrinol Invest; 2001 May; 24(5):315-20. PubMed ID: 11407650
[TBL] [Abstract][Full Text] [Related]
16. Childhood Sustained Hypercalcemia: A Diagnostic Challenge.
Çullas İlarslan NE; Şıklar Z; Berberoğlu M
J Clin Res Pediatr Endocrinol; 2017 Dec; 9(4):315-322. PubMed ID: 28443817
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for skeletal-related events (SREs) and factors affecting SRE-free survival for nonsmall cell lung cancer patients with bone metastases.
Ulas A; Bilici A; Durnali A; Tokluoglu S; Akinci S; Silay K; Oksuzoglu B; Alkis N
Tumour Biol; 2016 Jan; 37(1):1131-40. PubMed ID: 26276360
[TBL] [Abstract][Full Text] [Related]
18. A multicenter and open label clinical trial of zoledronic acid 4 mg in patients with hypercalcemia of malignancy.
Kawada K; Minami H; Okabe K; Watanabe T; Inoue K; Sawamura M; Yagi Y; Sasaki T; Takashima S
Jpn J Clin Oncol; 2005 Jan; 35(1):28-33. PubMed ID: 15681601
[TBL] [Abstract][Full Text] [Related]
19. Malignant hypercalcemia--a hospital survey.
Blomqvist CP
Acta Med Scand; 1986; 220(5):455-63. PubMed ID: 3812029
[TBL] [Abstract][Full Text] [Related]
20. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
